BioConsortia obtains key US patent for advanced microbial selection

A U.S. patent has been granted to BioConsortia Inc for its Advanced Microbial Selection (AMS) process, giving BioConsortia a proprietary research and development platform to rapidly identify teams of microbes and develop products that protect and enhance crop yields. 

The AMS technology puts efficient and harmonious plant colonization at the forefront of experimentation. The benefits of AMS are the microbes are good plant colonizers and compatible with other microbes in the consortia and survive standard chemical crop inputs. BioConsortia is focused on eliminating as many stress situations as possible. 

“This secures BioConsortia a strong patent position that is complemented by our outstanding research team and internal know-how in the field of microbiome analysis and microbial product development,” CEO Marcus Meadows-Smith said. “Our patents reinforce our leadership position and enable the launch of highly efficacious and consistent products.”

The AMS patent is the first U.S. patent granted from a group filed by BioConsortia about the AMS process and microbial consortia for plant enhancement. BioConsortia is tasked with developing highly effective microbial solutions that enhance plant phenotypes and increase crop yields. The AMS process enriches the crop microbiome, allowing BioConsortia to identify microbes that influence the beneficial traits in plants.

Organizations in this Story

BioConsortia, Inc.

Want to get notified whenever we write about BioConsortia, Inc. ?
Next time we write about BioConsortia, Inc., we'll email you a link to the story. You may edit your settings or unsubscribe at any time.